FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 265

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
LYEL Nasdaq Lyell Immunopharma, Inc. 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBIO Nasdaq Mustang Bio, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MCRB Nasdaq Seres Therapeutics, Inc. 2830
MDGL Nasdaq Madrigal Pharmaceuticals, Inc. 2830
MENS Nasdaq Jyong Biotech Ltd. 2830
MESO Nasdaq Mesoblast Limited 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLTX Nasdaq MoonLake Immunotherapeutics 2830
MREO Nasdaq Mereo BioPharma Group plc 2830
MRK New York Merck & Co., Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
NATR Nasdaq Natures Sunshine Products, Inc. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NBY NYSE American NovaBay Pharmaceuticals, Inc. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2830
NTRB Nasdaq Nutriband Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
OGEN NYSE American Oragenics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
OSRH Nasdaq OSR Holdings, Inc. 2830
PAHC Nasdaq Phibro Animal Health Corporation 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBM Nasdaq Psyence Biomedical Ltd. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
PCRX Nasdaq Pacira BioSciences, Inc. 2830
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PEPG Nasdaq PepGen Inc. 2830
PHAR Nasdaq Pharming Group N.V. 2830
PHAT Nasdaq Phathom Pharmaceuticals, Inc. 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PLRX Nasdaq Pliant Therapeutics, Inc. 2830
PLYX Nasdaq Polaryx Therapeutics, Inc. 2830
PMN Nasdaq ProMIS Neurosciences, Inc. 2830
PPBT Nasdaq Purple Biotech Ltd 2830
PPCB Nasdaq Propanc Biopharma, Inc. 2830
PRFX Nasdaq PRF Technologies Ltd. 2830
PRGO New York Perrigo Company plc 2830
PRTA Nasdaq Prothena Corporation plc 2830
PTCT Nasdaq PTC Therapeutics, Inc. 2830
PTHS NYSE American Pelthos Therapeutics Inc. 2830
Results 150 through 200 of 265